Lifastuzumab Recombinant Monoclonal Antibody for SPR, Flow, ELISA, Functional Lifastuzumab vedotin is under investigation in clinical trial NCT01363947 (Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung
Lifastuzumab Recombinant Monoclonal Antibody for SPR, Flow, ELISA, Functional Lifastuzumab vedotin is under investigation in clinical trial NCT01363947 (Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung
Read more ...